Home › Funds › Ninety One SA (PTY) Ltd › EW

Ninety One SA (PTY) Ltd position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Ninety One SA (PTY) Ltd reported holding 265,013 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$23.0M, representing 1.15% of its reported portfolio and ranking #10 among its reported holdings. Ninety One SA (PTY) Ltd has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)265.01K sh
Reported value held$22.96M
Portfolio Weight1.15%
First reportedQ4 2023
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Ninety One SA (PTY) Ltd's EW position evolved

Ninety One SA (PTY) Ltd first disclosed a stake in EW in Q4 2023 at 8,993 shares (US$686K). The position peaked in Q2 2026 at 262,942 shares, worth US$23.8M. Across 12 filings, Ninety One SA (PTY) Ltd increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 265,013 shares valued at US$23.0M — an increase of 2,071 shares quarter over quarter.. Notable position changes include a 814% increase in Q1 2024 (shares fell 3% over the following quarter), a 173% increase in Q1 2025 (shares rose 8% over the following quarter), a 41% increase in Q1 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 8.99K $685.72K New
Q1 2024 82.18K $7.84M Add
Q2 2024 71.82K $6.66M Reduce
Q3 2024 75.52K $4.98M Add
Q4 2024 53.10K $3.93M Reduce
Q1 2025 144.98K $10.46M Add
Q2 2025 139.78K $10.89M Reduce
Q3 2025 177.43K $13.76M Add
Q4 2025 181.51K $15.47M Add
Q1 2026 255.91K $20.18M Add
Q2 2026 262.94K $23.75M Add
Q3 2026 265.01K $22.96M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Ninety One SA (PTY) Ltd held EW?

Ninety One SA (PTY) Ltd has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Ninety One SA (PTY) Ltd's current position in EW?

As of Q3 2026, Ninety One SA (PTY) Ltd holds 265.01K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $22.96M, representing 1.15% of its reported portfolio and ranking #10.

Has Ninety One SA (PTY) Ltd been buying or selling EW?

In the latest 13F filing (Q3 2026), Ninety One SA (PTY) Ltd increased its position in EW. The position peaked in Q2 2026 at 262.94K shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.